FREMONT, Calif., Feb. 9, 2012 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB: WGBS), an emerging genomic analysis company, today announced that the company will deliver its corporate presentation at the 14th Annual BIO CEO & Investor Conference, February 13 and 14, 2012 at the Waldorf Astoria, New York, ... read more

FREMONT, Calif., Jan. 18, 2012 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced that Scott R. Davidson and Joseph F. Pesce, CPA, have joined the company's Board of Directors. Scott R. Davidson currently serves as Managing Director at Great Point Partners, ... read more

FREMONT, Calif., Jan. 5, 2012 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced that the company plans to deliver its corporate presentation at the 5(th) Annual OneMedForum San Francisco 2012, at the Sir Francis Drake Hotel, San Francisco, Calif., January 9-12, ... read more

FREMONT, Calif., Dec. 8, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced that the company plans to deliver its corporate presentation at the Oppenheimer 22nd Annual Healthcare Conference at the Waldorf-Astoria, New York, NY, December 13-14, 2011. The Company is scheduled to ... read more

FREMONT, Calif., Nov. 21, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today reported financial results for the three and nine months ended September 30, 2011 and announced a revised plan to commercialize and increase adoption of its SmartChip System. "During the third quarter of 2011 we ... read more

FREMONT, Calif., Oct. 20, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), an emerging genomic analysis company, today announced organizational changes to strengthen domain leadership and enhance commercialization expertise required to increase the adoption of its SmartChip System. As an initial step, the company has engaged Steve Lombardi, formerly President ... read more

FREMONT, Calif., Oct. 13, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), the provider of next-generation genomic analysis systems, announced that its SmartChip Real-Time PCR System was chosen by a German consortium to advance their research toward developing a reliable blood test for detection of cancer, cardiovascular and other diseases. ... read more

FREMONT, Calif., Oct. 12, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), the provider of next-generation genomic analysis systems, will demonstrate the success of its SmartChip Real-time PCR System in enabling new research applications at the premier human genetics meeting, the combined 12th International Congress of Human Genetics (ICHG) and the ... read more

FREMONT, Calif., Sept. 15, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB: WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that biotech industry leader Dr. Paul Schimmel, well known for his work in biophysical chemistry and molecular biology, has joined the WaferGen Scientific Advisory Board. Dr. Schimmel has been ... read more

FREMONT, Calif., Sept. 12, 2011 -- WaferGen Biosystems, Inc. (OTCBB:WGBSE), a leading developer of state-of-the-art genomic analysis systems, today reported financial results for the second quarter ended June 30, 2011. "During the second quarter, our principle focus was to secure adequate funding to commercialize ... read more

FREMONT, Calif., Aug. 23, 2011 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, announced today that it intends to file its Quarterly Report on Form 10-Q for the period ended June 30, 2011 within two weeks. The company had previously filed a Form ... read more